Paraneoplastic Autoimmune Neurological Disorders [Featured Topic]

The Paraneoplastic Autoantibody Evaluation developed by the Mayo Clinic Neuroimmunology Laboratory, is a patient-individualized, physician-directed consultation that aids the diagnosis of autoimmune disorders of brain, nerve, and muscle that reflect an immune response initiated by unsuspected cancer.

Comprehensive serological testing is the most expeditious and cost-effective screening for evidence of cancer in a patient presenting with a subacute neurological disorder. Prompt and comprehensive serological analysis is also in the best interest of the patient to assure early diagnosis and appropriate therapy in the window of reversibility.

Click here to learn more about paraneoplastic disorder testing at Mayo Medical Laboratories.


Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.